| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-16 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-15 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |